Clinical Trial Update: Low Doses of Cholestyramine in the Treatment of Hyperthyroidism [NA]

View source ↗

Summary

A completed clinical trial investigated low doses of cholestyramine for the treatment of Graves' disease-related hyperthyroidism.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graves Disease

Drugs mentioned

• Cholestyramine (cholestyramine)

Snippet

Sponsor: Shiraz University of Medical Sciences | Conditions: Graves Disease | NA | Status: COMPLETED